Chest Innovations
Palo Alto
About Chest Innovations
Chest Innovations has developed a minimally invasive medical device for taking endoscopic biopsy samples from the lung while preserving tissue and eliminating bleeding. The device, SureCore, is designed to be used by surgeons, radiologists, and pulmonologists to take samples during biopsies that preserve tissue and eliminate bleeding.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Estimated revenue: $1K – $10K
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2011)
- Website: chestinnovations.com
Industries & Categories
Biotechnology, Health Care, Medical Device, Productivity Tools
Canonical: https://fsome.com/organization/chest-innovations-3624564 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.